Jfl Life Sciences Ltd Quarterly Result
JFL Life Sciences Ltd
NSE: JFLLIFE
Net Profit - Last Quarter
JFL Life Sciences Ltd Quarterly Results Key Highlights
- The revenue of JFL Life Sciences Ltd for the Mar '26 is ₹ 63.09 crore as compare to the Dec '25 revenue of ₹ 26.85 crore.
- This represent the growth of 134.97% The ebitda of JFL Life Sciences Ltd for the Mar '26 is ₹ 3.56 crore as compare to the Dec '25 ebitda of ₹ 3.36 crore.
- This represent the growth of 5.95% The net profit of JFL Life Sciences Ltd for the Mar '26 is ₹ 1.66 crore as compare to the Dec '25 net profit of ₹ 2.02 crore.
- This represent the decline of -17.82%.
JFL Life Sciences Ltd Quarterly Results Analysis
Market Price of JFL Life Sciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 29 Jul 2026 | 12.35 |
| 28 Jul 2026 | 11.8 |
| 27 Jul 2026 | 11.25 |
| 24 Jul 2026 | 11.35 |
| 23 Jul 2026 | 10.85 |
| 22 Jul 2026 | 10.35 |
| 21 Jul 2026 | 10.5 |
| 20 Jul 2026 | 11 |
| 17 Jul 2026 | 10.5 |
| 16 Jul 2026 | 11 |
Historical Revenue of JFL Life Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of JFL Life Sciences Ltd
Historical EBITDA of JFL Life Sciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of JFL Life Sciences Ltd
Historical Net Profit of JFL Life Sciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of JFL Life Sciences Ltd
JFL Life Sciences Ltd News Hub
Board of JFL Life Sciences recommends final dividend
JFL Life Sciences announced that the Board of Directors of the Company at its meeting held on 2 Augu
Read more
02 Aug 24
JFL Life Sciences to hold board meeting
JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 31 August 2024. Po
Read more
24 Aug 24
JFL Life Sciences AGM scheduled
JFL Life Sciences announced that the 14th Annual General Meeting (AGM) of the company will be held o
Read more
02 Sept 24
JFL Life Sciences announces board meeting date
JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 27 March 2025. Pow
Read more
20 Mar 25
Popular Search
About JFL Life Sciences Ltd
- JFL Life Sciences Limited was incorporated as JFL Life Sciences Private Limited' on April 25, 2010 as a Private Limited Company.
- Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to JFL Life Sciences Limited', on March 3, 2022.
- The Company manufactures and market pharmaceutical products.
- The major products are Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and capsules (General) and Oral Rehydration Solutions (ORS). In August 2022, the Company launched an IPO of 29,78,000 Equity Shares by raising funds aggregating to Rs. 18.16 Crore. The Company export products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters.
